Local Tech Wire

RESEARCH TRIANGLE PARK, N.C. – could be joining another Triangle-area firm, Red Hat, as a leader in open source. But in a different way – open source drug development instead of open source software.

So writes the Wall Street Journal in a report about GSK’s previously disclosed efforts to open up its efforts to combat malaria.

“A decade ago, the Linux operating system helped spark a revolution in how software is developed. A move by GlaxoSmithKline PLC could test how well similar open-source principles work for developing new drugs,” the Journal says.

LTW reported about the GSK initiative with and an accompanying post with about "Open Labs, Open Minds."

LTW had another post following up on the program in April to

“Glaxo and others hope that sharing information and working together will lead scientists to come up with a drug for treating the mosquito-borne disease faster than the company could on its own,” it adds.

Read the details at

GSK’s U.S. headquarters are located in RTP.

Get the latest news alerts: at Twitter.